• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”

by Sarah Moniz | Feb 6, 2018

Immuno-informatics: Mining the genome for Vaccine Components

Immuno-informatics: Mining the genome for Vaccine Components

by Adam | Oct 22, 2016

Immunology and Cell Biology. Immunology and Cell Biology (2002) 80, 255–269.
Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes

Analyzing Mycobacterium tuberculosis proteomes for candidate vaccine epitopes

by Adam | Oct 22, 2016

Tuberculosis (Edinb). 2005; 85(1-2):95-105.
Developing an epitope-driven tuberculosis (TB) vaccine

Developing an epitope-driven tuberculosis (TB) vaccine

by Adam | Oct 22, 2016

Vaccine. 2005 Mar 18; 23(17-18):2121-31.
Confirmation of Immunogenic Consensus Sequence HIV-1 T-cell Epitopes in Bamako, Mali and Providence, Rhode Island

Confirmation of Immunogenic Consensus Sequence HIV-1 T-cell Epitopes in Bamako, Mali and Providence, Rhode Island

by Adam | Oct 22, 2016

Human Vaccines 2006 June; 2(3), 119-128.
« Older Entries

Recent Posts

  • The Amsterdam Immunogenicity & Tolerance Seminar: 2025
  • EpiVax Seminars in Tokyo
  • The Role of Treg Epitopes (Tregitopes) in Antibody Maturation Uncovered in New EpiVax Study: Implications for Therapeutic Antibodies
  • March of the Teenage B Cells
  • EpiVax Strengthens Technology Leadership Amid Immunoinformatics Advancements

Recent Comments

No comments to show.

Join our newsletter

 Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CSO, Dr. Annie De Groot. 

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline